Steve Snyder

Steve Snyder has over 40 years of work experience in the pharmaceutical and biotechnology industry. Steve is currently the Vice President of Pathology Strategy and Solutions at StageBio. Prior to this, they were the President of Outsourcing Support Services, Inc, where they monitored non-clinical studies and evaluated research operations for effectiveness and regulatory compliance. Steve also worked as the Director of Strategic Business Development at Charles River Laboratories. Steve Snyder began their career as a Sr. Research Associate at Ortho-McNeil Pharmaceutical and later became the Head of Toxicology Studies at Eli Lilly and Company.

Steve Snyder has a Bachelor of Science degree in Biology from Bloomsburg University of Pennsylvania and a Master of Science degree in Biology from Villanova University.